Navigation Links
Spectrum Pharmaceuticals to Present at the 2007 BIOCOM Investor Conference
Date:10/31/2007

IRVINE, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc., (Nasdaq: SPPI) announced today that it will present an overview of the Company on Thursday, November 1, 2007, at 2:00 p.m. Pacific, at the BIOCOM Investor Conference, being held at the Marriott Del Mar in San Diego, California. Spectrum's presentation will be held in Room 3 of the Rancho Santa Fe Ballroom.

The live webcast of Spectrum's presentation will be available at http://www.spectrumpharm.com. Replays will be available for 30 days.

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals acquires, develops and commercializes a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease. For more information, please visit our website at http://www.spectrumpharm.com.

Forward-looking statement -- This press release may contain forward- looking statements regarding future events and the future performance of Spectrum Pharmaceuticals that involve risks and uncertainties that could cause actual results to differ materially. These statements include but are not limited to statements that relate to our business and its future, Spectrum's ability to identify, acquire, develop and commercialize its portfolio of drug candidates, the Company's promising pipeline, and any statements
'/>"/>

SOURCE Spectrum Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Tigecycline – New Generation Tetracycline With Broad Spectrum Antibacterial Activit
2. Simple Eye Movement Test For Early Detection Of Fetal Alcohol Spectrum Disorder
3. Lack Of Social Skills Linked To Autism Spectrum Disorder (ASD)
4. Broad Spectrum Antibiotic Available for Antibiotic Resistant Bacteria
5. Fetal Alcohol Spectrum Disorder in Children Can Be Diagnosed With Eye Movement Tests
6. Younger Siblings of Children With Autism Spectrum Disorders Score Low
7. Bipolar Spectrum Disorder may Be Under-recognized for Spectrum Disorder: Study
8. Supply of Radiopharmaceuticals Hampered by Attacks
9. FDA approves Watson Pharmaceuticals Oxytrol patch
10. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
11. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 Kleritec, Inc. announced the addition ... http://www.kleritec.com . In the recent expansion Kleritec ... activities packages for pre-school and day care providers. The ... to aid teachers across the United States the ability ... , Included in the art and activities packages is ...
(Date:6/19/2013)... York, NY (PRWEB) June 19, 2013 Citi Bike ... There’s no way for Dr. David Perna to know for sure ... service, but he’s happy that they’ll have the option. In ... healthier lives—especially if it might also make it more convenient for ... Dr. Perna is the Director of Complimentary Alternative Medicine at Back ...
(Date:6/19/2013)... a major international study led by researchers at The ... therapy ibrutinib continues to show remarkable promise for the ... , The most recent interim findings of the 18-center ... New England Journal of Medicine . Previous interim findings ... Society of Hematology Annual Meeting and Exposition. , ...
(Date:6/19/2013)... as many emergency department visits if their primary care ... days a week, according to new research from child ... Hopkins University. , The new study was published online ... and will be presented at the AcademyHealth Annual Research ... understanding where primary care practices and medical home programs ...
(Date:6/19/2013)... Nearly 70 percent of Americans are on ... half take two, Mayo Clinic researchers say. Antibiotics, ... their study found. Twenty percent of patients are ... the findings, published online in the journal ... audio and video of Dr. Jennifer St. Sauver ...
Breaking Medicine News(10 mins):Health News:Kleritec Announces Addition of Educational Products. 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2
... , , MIAMI, Dec. ... creator of the immensely popular Dr. Siegal,s COOKIE DIET® weight-loss ... brand,s global distributor, this morning filed a lawsuit against reality ... made on her Twitter page on October 29, 2009. A ...
... SAN JOSE, Calif. , Dec. 29 The Coalition for ... advocacy, research support and awareness, even in a year plagued ... has no known cause, no FDA-approved treatment, and no cure. ... advancing the effort to build awareness of the disease throughout ...
... , Advisories Eased for Seven Water Bodies; ... State officials today released updated fish consumption advisories that ... had not previously been on the list, but also eases ... , The advisories were developed through an interagency partnership between ...
... , ... heels of its remarkable success in alcohol recovery, National Institute For Alcohol Recovery (NIFAR®) ... resolutions....(read more) , ... Gaithersburg, MD (PRWEB) December 29, 2009 -- On the heels of its remarkable success ...
... type 2 diabetes, prediabetes sooner, with no fasting, , TUESDAY, ... clinical guidelines, the American Diabetes Association is promoting a more ... diagnosis of type 2 diabetes and prediabetes. , Long used ... average blood sugar levels for the previous two to three ...
... , WASHINGTON, Dec. 29 ... Wellness Challenge -- three promotions spanning the next five ... their health goals in 2010. , "The goal of ... change their wellness habits, which can be difficult," says William ...
Cached Medicine News:Health News:Kim Kardashian Sued by Dr. Siegal's COOKIE DIET(R) Creator Dr. Sanford Siegal 2Health News:Kim Kardashian Sued by Dr. Siegal's COOKIE DIET(R) Creator Dr. Sanford Siegal 3Health News:Kim Kardashian Sued by Dr. Siegal's COOKIE DIET(R) Creator Dr. Sanford Siegal 4Health News:Kim Kardashian Sued by Dr. Siegal's COOKIE DIET(R) Creator Dr. Sanford Siegal 5Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 2Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 4Health News:Updated Fish Consumption Advisories Issued for 2010 2Health News:Updated Fish Consumption Advisories Issued for 2010 3Health News:Now Millions Suffering With Alcohol Addiction Can Get Breakthrough Recovery in Ultimate Privacy 2Health News:Now Millions Suffering With Alcohol Addiction Can Get Breakthrough Recovery in Ultimate Privacy 3Health News:New Guidelines Urge A1C Test for Diabetes Diagnosis 2Health News:'Life...supplemented' Announces America's Wellness Challenge 2Health News:'Life...supplemented' Announces America's Wellness Challenge 3
(Date:6/19/2013)... The Physician-Patient Alliance for Health & Safety recently released three ... urgently address this issue has been emphasized by The ... device alarm safety in hospitals." According to The Joint Commission ... there were 98 alarm related events reported, of which: ... resulted in permanent loss of function (13%) , 5 ...
(Date:6/19/2013)... NEW YORK , June 19, 2013   ... dedicated to finding a cure for brain cancer, today ... ) a grant to support the clinical investigation of ... a recurrent high grade glioma brain cancer (Grade 3 ... company developing novel treatments for advanced cancer, with an ...
(Date:6/19/2013)...   Nektar Therapeutics (Nasdaq: NKTR ) ... (HAL) study for NKTR-181, a first-in-class, opioid analgesic ... This slow rate of entry is designed to reduce the ... to current opioid analgesics. 1 In the study data ... placebo in "drug liking" and "feeling high" scores and had ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9
... Study Showed 11 Percent Fewer RA Patients,Reported ... Therapy,Compared to Methotrexate Alone, BARCELONA, Spain, June ... one of the most common causes of,disability ... today show that,rheumatoid arthritis (RA) patients treated ...
... Influenza Conference, HIGH WYCOMBE, England, June 18, 2007 ... new flu vaccine has the,potential to protect against ... presented today by PepTcell, at the 2007,Options for ... Canada. , The pre-clinical results, which will be ...
Cached Medicine Technology:Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4
For rigid cystoscopes and rigid-, and semi-rigid ureteroscopes, these forceps have an integral handle design and a diameter of 5 Fr with a working length of 58 cm....
Fulgurating Electrode, 2 F...
Used to obtain biopsy specimens from pathological lesions in the ureter, renal pelvis, infundibula, or calyces. Supplied sterile in peel-open packages. Intended for one-time use....
Used to obtain tissue biopsy under direct vision. Cup Biopsy Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: